161 related articles for article (PubMed ID: 33517283)
1. IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis.
Inoue M; Takeuchi H; Matsuda S; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Kitagawa Y
Anticancer Res; 2021 Feb; 41(2):783-794. PubMed ID: 33517283
[TBL] [Abstract][Full Text] [Related]
2. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma.
Wu J; Gao FX; Wang C; Qin M; Han F; Xu T; Hu Z; Long Y; He XM; Deng X; Ren DL; Dai TY
J Exp Clin Cancer Res; 2019 Jul; 38(1):321. PubMed ID: 31324197
[TBL] [Abstract][Full Text] [Related]
3. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma.
Sueoka H; Hirano T; Uda Y; Iimuro Y; Yamanaka J; Fujimoto J
Surgery; 2014 Apr; 155(4):640-9. PubMed ID: 24582495
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis.
Dong H; Xu J; Li W; Gan J; Lin W; Ke J; Jiang J; Du L; Chen Y; Zhong X; Zhang D; Yeung SJ; Li X; Zhang H
J Pathol; 2017 Mar; 241(4):448-462. PubMed ID: 27801498
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
[TBL] [Abstract][Full Text] [Related]
6. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
Lo MC; Yip TC; Ngan KC; Cheng WW; Law CK; Chan PS; Chan KC; Wong CK; Wong RN; Lo KW; Ng WT; Lee WM; Tsao SW; Kwong LW; Lung ML; Mak NK
Cancer Lett; 2013 Jul; 335(1):81-92. PubMed ID: 23403077
[TBL] [Abstract][Full Text] [Related]
7. Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Sawayama H; Ogata Y; Ishimoto T; Mima K; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Yoshida N; Baba H
Cancer Sci; 2019 May; 110(5):1705-1714. PubMed ID: 30861255
[TBL] [Abstract][Full Text] [Related]
8. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
[TBL] [Abstract][Full Text] [Related]
9. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
10. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
12. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
13. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
[TBL] [Abstract][Full Text] [Related]
14. The CXCR2/CXCL2 signalling pathway - An alternative therapeutic approach in high-grade glioma.
Acker G; Zollfrank J; Jelgersma C; Nieminen-Kelhä M; Kremenetskaia I; Mueller S; Ghori A; Vajkoczy P; Brandenburg S
Eur J Cancer; 2020 Feb; 126():106-115. PubMed ID: 31927212
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
Tang C; He JY; Yu C; Wang PJ; Huang SH; Zheng HJ; Yan DQ; Zhang JH; Li Y
J Cell Biochem; 2019 Jun; 120(6):10678-10687. PubMed ID: 30652343
[TBL] [Abstract][Full Text] [Related]
16. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Nakade H; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Miyao S; Sho M
Int J Clin Oncol; 2020 Mar; 25(3):446-455. PubMed ID: 31535245
[TBL] [Abstract][Full Text] [Related]
18. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
19. CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.
Uchi Y; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2016 Jul; 16():514. PubMed ID: 27439769
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
